Longer Forms of Amyloid Beta Protein: Implications for the Mechanism of Intramembrane Cleavage by Gamma-secretase

Overview

Journal J Neurosci

Specialty Neurology

Date 2005 Jan 14

PMID 15647487

Citations 182

Authors

Yue Qi-Takahara

Maho Morishima-Kawashima

Yu Tanimura

Georgia Dolios

Naoko Hirotani

Yuko Horikoshi

Fuyuki Kametani

Masahiro Maeda

Takaomi C Saido

Rong Wang

Yasuo Ihara

Affiliations

Soon will be listed here.

Abstract

Gamma-cleavage of beta-amyloid precursor protein (APP) in the middle of the cell membrane generates amyloid beta protein (Abeta), and epsilon-cleavage, approximately 10 residues downstream of the gamma-cleavage site, releases the APP intracellular domain (AICD). A significant link between generation of Abeta and AICD and failure to detect AICD41-99 led us to hypothesize that epsilon-cleavage generates longer Abetas, which are then processed to Abeta40/42. Using newly developed gel systems and an N-end-specific monoclonal antibody, we have identified the longer Abetas (Abeta1-43, Abeta1-45, Abeta1-46, and Abeta1-48) within the cells and in brain tissues. The production of these longer Abetas as well as Abeta40/42 is presenilin dependent and is suppressed by {1S-benzyl-4R-[1S-carbamoyl-2-phenylethylcarbamoyl-1S-3-methylbutylcarbamoyl]-2R-hydroxy-5-phenylpentyl}carbamic acid tert-butyl ester, a transition state analog inhibitor for aspartyl protease. In contrast, N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester, a potent dipeptide gamma-secretase inhibitor, builds up Abeta1-43 and Abeta1-46 intracellularly, which was also confirmed by mass spectrometry. Notably, suppression of Abeta40 appeared to lead to an increase in Abeta43, which in turn brings an increase in Abeta46, in a dose-dependent manner. We therefore propose an alpha-helical model in which longer Abeta species generated by epsilon-cleavage is cleaved at every three residues in its carboxyl portion.

Citing Articles

γ-Secretase modulator resistance of an aggressive Alzheimer-causing presenilin mutant can be overcome in the heterozygous patient state by a set of advanced compounds.

Trambauer J, Sarmiento R, Garringer H, Salbaum K, Pedro L, Crusius D Alzheimers Res Ther. 2025; 17(1):49.

PMID: 39972463 PMC: 11837686. DOI: 10.1186/s13195-025-01680-3.

The pathogenicity of PSEN2 variants is tied to Aβ production and homology to PSEN1.

Liu L, Schultz S, Saba A, Yang H, Li A, Selkoe D Alzheimers Dement. 2024; 20(12):8867-8877.

PMID: 39559858 PMC: 11667513. DOI: 10.1002/alz.14339.

The Dual Role of Amyloid Beta-Peptide in Oxidative Stress and Inflammation: Unveiling Their Connections in Alzheimer's Disease Etiopathology.

Fanlo-Ucar H, Picon-Pages P, Herrera-Fernandez V, Ill-Raga G, Munoz F Antioxidants (Basel). 2024; 13(10).

PMID: 39456461 PMC: 11505517. DOI: 10.3390/antiox13101208.

Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations.

Wang J, Fourriere L, Gleeson P Biochem J. 2024; 481(19):1297-1325.

PMID: 39302110 PMC: 11555708. DOI: 10.1042/BCJ20240056.

Oligomer Formation by Physiologically Relevant C-Terminal Isoforms of Amyloid -Protein.

Pandey R, Urbanc B Biomolecules. 2024; 14(7).

PMID: 39062488 PMC: 11274879. DOI: 10.3390/biom14070774.

References

Lichtenthaler S, Wang R, Grimm H, Uljon S, Masters C, Beyreuther K . Mechanism of the cleavage specificity of Alzheimer's disease gamma-secretase identified by phenylalanine-scanning mutagenesis of the transmembrane domain of the amyloid precursor protein. Proc Natl Acad Sci U S A. 1999; 96(6):3053-8. PMC: 15893. DOI: 10.1073/pnas.96.6.3053. View

Wolfe M, Xia W, Ostaszewski B, Diehl T, Kimberly W, Selkoe D . Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature. 1999; 398(6727):513-7. DOI: 10.1038/19077. View

Lichtenthaler S, Multhaup G, Masters C, Beyreuther K . A novel substrate for analyzing Alzheimer's disease gamma-secretase. FEBS Lett. 1999; 453(3):288-92. DOI: 10.1016/s0014-5793(99)00730-9. View

Vassar R, Bennett B, Kahn S, Mendiaz E, Denis P, Teplow D . Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science. 1999; 286(5440):735-41. DOI: 10.1126/science.286.5440.735. View

Tomita T, Takikawa R, Koyama A, Morohashi Y, Takasugi N, Saido T . C terminus of presenilin is required for overproduction of amyloidogenic Abeta42 through stabilization and endoproteolysis of presenilin. J Neurosci. 1999; 19(24):10627-34. PMC: 6784929. View

Sudoh S, Hua G, Kawamura Y, Maruyama K, Komano H, Yanagisawa K . Intracellular site of gamma-secretase cleavage for Abeta42 generation in neuro 2a cells harbouring a presenilin 1 mutation. Eur J Biochem. 2000; 267(7):2036-45. DOI: 10.1046/j.1432-1327.2000.01206.x. View

Li Y, Xu M, Lai M, Huang Q, Castro J, Harrison T . Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1. Nature. 2000; 405(6787):689-94. DOI: 10.1038/35015085. View

Shearman M, Beher D, CLARKE E, Lewis H, Harrison T, Hunt P . L-685,458, an aspartyl protease transition state mimic, is a potent inhibitor of amyloid beta-protein precursor gamma-secretase activity. Biochemistry. 2000; 39(30):8698-704. DOI: 10.1021/bi0005456. View

Seiffert D, Bradley J, Rominger C, Rominger D, Yang F, Meredith Jr J . Presenilin-1 and -2 are molecular targets for gamma-secretase inhibitors. J Biol Chem. 2000; 275(44):34086-91. DOI: 10.1074/jbc.M005430200. View

10.

Dovey H, John V, Anderson J, Chen L, de Saint Andrieu P, Fang L . Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain. J Neurochem. 2001; 76(1):173-81. DOI: 10.1046/j.1471-4159.2001.00012.x. View

11.

Selkoe D . Alzheimer's disease: genes, proteins, and therapy. Physiol Rev. 2001; 81(2):741-66. DOI: 10.1152/physrev.2001.81.2.741. View

12.

Gu Y, Misonou H, Sato T, Dohmae N, Takio K, Ihara Y . Distinct intramembrane cleavage of the beta-amyloid precursor protein family resembling gamma-secretase-like cleavage of Notch. J Biol Chem. 2001; 276(38):35235-8. DOI: 10.1074/jbc.C100357200. View

13.

Sastre M, Steiner H, Fuchs K, Capell A, Multhaup G, Condron M . Presenilin-dependent gamma-secretase processing of beta-amyloid precursor protein at a site corresponding to the S3 cleavage of Notch. EMBO Rep. 2001; 2(9):835-41. PMC: 1084035. DOI: 10.1093/embo-reports/kve180. View

14.

Yu C, Kim S, Ikeuchi T, Xu H, Gasparini L, Wang R . Characterization of a presenilin-mediated amyloid precursor protein carboxyl-terminal fragment gamma. Evidence for distinct mechanisms involved in gamma -secretase processing of the APP and Notch1 transmembrane domains. J Biol Chem. 2001; 276(47):43756-60. DOI: 10.1074/jbc.C100410200. View

15.

Weggen S, ERIKSEN J, Das P, Sagi S, Wang R, Pietrzik C . A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature. 2001; 414(6860):212-6. DOI: 10.1038/35102591. View

16.

Weidemann A, Eggert S, Reinhard F, Vogel M, Paliga K, Baier G . A novel epsilon-cleavage within the transmembrane domain of the Alzheimer amyloid precursor protein demonstrates homology with Notch processing. Biochemistry. 2002; 41(8):2825-35. DOI: 10.1021/bi015794o. View

17.

Beher D, Wrigley J, Owens A, Shearman M . Generation of C-terminally truncated amyloid-beta peptides is dependent on gamma-secretase activity. J Neurochem. 2002; 82(3):563-75. DOI: 10.1046/j.1471-4159.2002.00985.x. View

18.

Lammich S, Okochi M, Takeda M, Kaether C, Capell A, Zimmer A . Presenilin-dependent intramembrane proteolysis of CD44 leads to the liberation of its intracellular domain and the secretion of an Abeta-like peptide. J Biol Chem. 2002; 277(47):44754-9. DOI: 10.1074/jbc.M206872200. View

19.

Okochi M, Steiner H, Fukumori A, Tanii H, Tomita T, Tanaka T . Presenilins mediate a dual intramembranous gamma-secretase cleavage of Notch-1. EMBO J. 2002; 21(20):5408-16. PMC: 129073. DOI: 10.1093/emboj/cdf541. View

20.

Qi Y, Morishima-Kawashima M, Sato T, Mitsumori R, Ihara Y . Distinct mechanisms by mutant presenilin 1 and 2 leading to increased intracellular levels of amyloid beta-protein 42 in Chinese hamster ovary cells. Biochemistry. 2003; 42(4):1042-52. DOI: 10.1021/bi0267590. View